Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia

CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients

(2011) S R Park et al.   BRITISH JOURNAL OF CANCER

DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma

(2011) Ji-Youn Han et al.   CANCER

The IFNG (IFN- ) Genotype Predicts Cytogenetic and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia

(2010) D. H. Kim et al.   CLINICAL CANCER RESEARCH

Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients

(2010) Sara S. Strom et al.   LEUKEMIA & LYMPHOMA

Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia

(2009) D. H. Kim et al.   CLINICAL CANCER RESEARCH

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials

(2008) S. Branford et al.   BLOOD

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

(2008) L Paré et al.   BRITISH JOURNAL OF CANCER

BCR/ABL and Other Kinases from Chronic Myeloproliferative Disorders Stimulate Single-Strand Annealing, an Unfaithful DNA Double-Strand Break Repair

(2008) K. Cramer et al.   CANCER RESEARCH

Current and future perspectives on the TARGET system: the registration system for Glivec® established by the JSH

(2008) Masahiro Kizaki et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Chronic myeloid leukemia in Asia

(2008) Wing Y. Au et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

STI571 reduces NER activity in BCR/ABL-expressing cells

(2008) Tomasz Sliwinski et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Modulation of DNA damage/DNA repair capacity by XPC polymorphisms

(2007) Yimin Zhu et al.   DNA REPAIR

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

(2007) K.D. STEFFENSEN et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER